中国老年人肌少症诊疗专家共识(2021)

2021-08-17 中华医学会老年医学分会 中华老年医学杂志

目前肌少症已成为老年人常见疾病,给我同医疗系统及社会造成了沉重的负担。

中文标题:

中国老年人肌少症诊疗专家共识(2021)

发布日期:

2021-08-17

简要介绍:

目前肌少症已成为老年人常见疾病,给我同医疗系统及社会造成了沉重的负担。尽管欧洲、北美以及亚洲肌少症工作组等国际机构已各自出台肌少症防治专家共识以应对目前肌少症防控中的严峻局面,但我国对肌少症的认识尚处于初级阶段.仍存在对老年人肌少症的危害认知不足、评估方法不统一、诊疗欠规范、地区医疗水平不均衡等诸多问题。因此,由中华医学会老年医学分会、《中华老年医学杂志》编辑委员会发起.根据目前的国际规范结合我国国情,编写了适合我国老年人肌少症患者的诊疗规范共识,旨在为我国社区医疗机构、大型综合医院等医疗单位的老年医学工作者提供指导意见。

下载附件:

(因为版权问题,不支持下载)

评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193653, encodeId=a73e119365353, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:12:03 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182380, encodeId=27e7118238021, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c65626927, createdName=ms4000000359333269, createdTime=Sat Jan 08 22:48:01 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085767, encodeId=f1b01085e67be, content=有用1009863606, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13385627765, createdName=ms3000001637087988, createdTime=Thu Dec 30 11:10:37 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080282, encodeId=6c0a10802826e, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=786b1518596, createdName=wu_kefen, createdTime=Wed Dec 15 13:04:29 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069827, encodeId=7265106982ec2, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92cf5649751, createdName=ms6000001893270953, createdTime=Sat Nov 13 09:55:09 CST 2021, time=2021-11-13, status=1, ipAttribution=)]
    2022-02-15 Daniel1218

    感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193653, encodeId=a73e119365353, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:12:03 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182380, encodeId=27e7118238021, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c65626927, createdName=ms4000000359333269, createdTime=Sat Jan 08 22:48:01 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085767, encodeId=f1b01085e67be, content=有用1009863606, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13385627765, createdName=ms3000001637087988, createdTime=Thu Dec 30 11:10:37 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080282, encodeId=6c0a10802826e, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=786b1518596, createdName=wu_kefen, createdTime=Wed Dec 15 13:04:29 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069827, encodeId=7265106982ec2, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92cf5649751, createdName=ms6000001893270953, createdTime=Sat Nov 13 09:55:09 CST 2021, time=2021-11-13, status=1, ipAttribution=)]
    2022-01-08 ms4000000359333269

    感谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1193653, encodeId=a73e119365353, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:12:03 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182380, encodeId=27e7118238021, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c65626927, createdName=ms4000000359333269, createdTime=Sat Jan 08 22:48:01 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085767, encodeId=f1b01085e67be, content=有用1009863606, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13385627765, createdName=ms3000001637087988, createdTime=Thu Dec 30 11:10:37 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080282, encodeId=6c0a10802826e, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=786b1518596, createdName=wu_kefen, createdTime=Wed Dec 15 13:04:29 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069827, encodeId=7265106982ec2, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92cf5649751, createdName=ms6000001893270953, createdTime=Sat Nov 13 09:55:09 CST 2021, time=2021-11-13, status=1, ipAttribution=)]
    2021-12-30 ms3000001637087988

    有用1009863606

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1193653, encodeId=a73e119365353, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:12:03 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182380, encodeId=27e7118238021, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c65626927, createdName=ms4000000359333269, createdTime=Sat Jan 08 22:48:01 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085767, encodeId=f1b01085e67be, content=有用1009863606, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13385627765, createdName=ms3000001637087988, createdTime=Thu Dec 30 11:10:37 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080282, encodeId=6c0a10802826e, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=786b1518596, createdName=wu_kefen, createdTime=Wed Dec 15 13:04:29 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069827, encodeId=7265106982ec2, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92cf5649751, createdName=ms6000001893270953, createdTime=Sat Nov 13 09:55:09 CST 2021, time=2021-11-13, status=1, ipAttribution=)]
    2021-12-15 wu_kefen

    感谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1193653, encodeId=a73e119365353, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:12:03 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182380, encodeId=27e7118238021, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c65626927, createdName=ms4000000359333269, createdTime=Sat Jan 08 22:48:01 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085767, encodeId=f1b01085e67be, content=有用1009863606, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13385627765, createdName=ms3000001637087988, createdTime=Thu Dec 30 11:10:37 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080282, encodeId=6c0a10802826e, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=786b1518596, createdName=wu_kefen, createdTime=Wed Dec 15 13:04:29 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069827, encodeId=7265106982ec2, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92cf5649751, createdName=ms6000001893270953, createdTime=Sat Nov 13 09:55:09 CST 2021, time=2021-11-13, status=1, ipAttribution=)]
    2021-11-13 ms6000001893270953

    感谢

    0

拓展阅读

2018 欧洲共识:肌少症的定义和诊断(更新版)

欧洲老年肌少症工作组(EWGSOP,European Working Group on Sarcopenia in Older People) · 2018-10-12

2018 ICSFR国际临床实践指南:肌少症的筛查,诊断和管理

国际肌少症和衰弱研究会议(ICSFR,International Conference on Sarcopenia and Frailty Research) · 2018-11-20

预防老年人肌少症核心信息中国专家共识(2021)

中华医学会老年医学分会 · 2021-08-30

2022 AWGS专家共识:营养在社区老年人肌肉健康中的作用

亚洲肌少症工作组(AWGS,Asian Working Group for Sarcopenia) · 2022-03-20